| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GAREM2 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.006 |
| mRNA | CD59 | CTRPv2 | pan-cancer | AAC | -0.4 | 0.006 |
| mRNA | TOPBP1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | ZNF438 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.006 |
| mRNA | ANXA2 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.006 |
| mRNA | C17orf105 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | UQCRFS1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.006 |
| mRNA | QRFPR | CTRPv2 | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | KRTAP12-2 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | PPP6R2 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.006 |
